General anaesthesia vs. Conscious sedation for transfemoral aortic valve implantation: A single UK centre before-and-after study

Anaesthesia

Volumn 71, Issue 8, 2016, Pages 892-900

  Miles, L F ^a   Joshi, K R ^b   Ogilvie, E H ^a   Densem, C G ^a   Klein, A A ^a   O'Sullivan, M ^a   Martinez, G ^a   Sudarshan, C D ^a   Abu Omar, Y ^a   Irons, J F ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Aortic stenosis; Cardiology; Conscious sedation; Transcatheter aortic valve implantation

Indexed keywords

INOTROPIC AGENT; LEVOBUPIVACAINE; PROPOFOL; REMIFENTANIL; SEVOFLURANE;

AGED; ARTICLE; BLADDER CATHETERIZATION; CONSCIOUS SEDATION; ENDOTRACHEAL INTUBATION; FEMALE; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NERVE BLOCK; POSITIVE END EXPIRATORY PRESSURE; TRANSCATHETER AORTIC VALVE IMPLANTATION; UNITED KINGDOM; VASCULAR ACCESS; VERY ELDERLY;

EID: 84978043837     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.13522     Document Type: Article

References (29)

1. Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Archives of Cardiovascular Diseases 2012; 105: 146–52.
2. Ludman PF, Moat N, de Belder MA, et al. Transcatheter aortic valve implantation in the UK: temporal trends, predictors of outcome and 6 year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation 2015; 131: 1181–90.
3. Ludman PF, UK TAVI Steering Group and the National Institute for Cardiovascular Outcomes Research. The UK transcatheter aortic valve implantation registry; one of the suite of registries hosted by the National Institute for Cardiovascular Outcomes Research (NICOR). Heart 2012; 98: 1787–9.
4. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. New England Journal of Medicine 2012; 336: 1705–15.
5. Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2485–91.
6. ISRCTN [Internet]. London: Current Controlled Trials, C/O BioMed Central. 2010. Identifier ISRCTN57819173. The United Kingdom Transcatheter Aortic Valve Implantation (UK TAVI) Trial. A multi-centre randomised controlled trial to assess the clinical effectiveness and cost utility of TAVI, compared with conventional surgical aortic valve replacement (AVR), in patients with severe symptomatic aortic stenosis at intermediate or high operative risk 2014 Mar. 12. Available from http://www.isrctn.com/ISRCTN57819173.
7. Dall'Ara G, Eltchaninoff H, Moat N, et al. Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation. International Journal of Cardiology 2014; 177: 448–54.
8. Bufton KA, Augoustinides JG, Cobey FC. Anesthesia for transfemoral aortic valve replacement in North America and Europe. Journal of Cardiothoracic and Vascular Anesthesia 2013; 27: 46–9.
9. Klein AA, Webb ST, Tsui S, Sudarshanc C, Shapiro L, Densem C. Transcatheter aortic valve insertion: anaesthetic implications of emerging new technology. British Journal of Anaesthesia 2009; 103: 792–9.
10. Checketts MR, Alladi R, Ferguson K, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2016; 71: 85–93.
11. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). European Journal of Cardiothoracic Surgery 1999; 16: 9–13.
12. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41–55.
13. Lopes AJ, Jorge S. The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clinical Kidney Journal 2013; 6: 8–14.
14. Roques F, Michel P, Goldstone AR, Nashef SAM. The logistic EuroSCORE. European Heart Journal 2003; 24: 882–3.
15. Klein AA, Skubas NJ, Ender J. Controversies and complications in the perioperative management of transcatheter aortic valve replacement. Anesthesia and Analgesia 2014; 119: 784–98.
16. Dehédin B, Guinot PG, Ibrahim H, et al. Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. Journal of Cardiothoracic and Vascular Anesthesia 2011; 25: 1036–43.
17. Motloch LJ, Rottlaender D, Reda S, et al. Local versus general anesthesia for transfemoral aortic valve implantation. Clinical Research in Cardiology 2012; 101: 45–53.
18. Goren O, Finkelstein A, Gluch A, Sheinberg N, Dery E, Matot I. Sedation or general anesthesia for patients undergoing transcatheter aortic valve implantation – does it affect outcome? An observational, single-center study. Journal of Clinical Anesthesia 2015; 27: 385–90.
19. Balanika M, Smyrli A, Samanidis G, et al. Anesthetic management of patients undergoing transcatheter aortic valve implantation. Journal of Cardiothoracic and Vascular Anesthesia 2014; 28: 285–9.
20. Iritakenishi T, Kamibayashi T, Torikai K, et al. Predictors of prolonged hemodynamic compromise after valve deployment during transcatheter aortic valve implantation. Journal of Cardiothoracic and Vascular Anesthesia 2015; 29: 868–74.
21. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. New England Journal of Medicine 2010; 362: 779–89.
22. Belletti A, Castro ML, Silvetti S, et al. The effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials. British Journal of Anaesthesia 2015; 115: 656–75.
23. Yamamoto M, Meguro K, Mouillet G, et al. Effect of local anaesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation. American Journal of Cardiology 2013; 111: 94–9.
24. Bergmann L, Kahlert P, Eggebrecht H, Frey U, Peters J, Kottenberg E. Transfemoral aortic valve implantation under sedation and monitored anaesthetic care – a feasibility study. Anaesthesia 2011; 66: 977–82.
25. Greif M, Lange P, Näbauer M, et al. Transcutaneous aortic valve replacement with the Edwards SAPIEN XT and Medtronic CoreValve prosthesis under fluoroscopic guidance and local anaesthesia only. Heart 2014; 100: 691–5.
26. Covello RD, Ruggeri L, Landoni G, et al. Transcatheter implantation of an aortic valve: anesthesiological management. Minerva Anestesiolgica 2010; 76: 100–8.
27. Ben-Dor I, Looser PM, Maluenda G, et al. Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation. Cardiovascular Revascularization Medicine 2012; 13: 207–10.
28. Ruparelia N, Prendergast BD. TAVI in 2015: who, where and how? Heart 2015; 101: 1422–31.
29. Frölich GM, Lansky AJ, Webb J, et al. Local versus general anesthesia for transcatheter aortic valve implantation (TAVI) – systematic review and meta-analysis. BMC Medicine 2014; 12: 41–50.